496 related articles for article (PubMed ID: 2673797)
1. A cytokine, lymphocyte blastogenesis inhibitory factor (LBIF), arrests mitogen-stimulated T lymphocytes at early G1 phase with no influence on interleukin 2 production and interleukin 2 receptor light chain expression.
Sugimura K; Ueda Y; Takeda K; Fukuda S; Tsukahara K; Habu Y; Fujiwara H; Azuma I
Eur J Immunol; 1989 Aug; 19(8):1357-64. PubMed ID: 2673797
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous production of a suppressor factor by a human macrophage-like cell line U937. II. Suppression of antigen- and mitogen-induced blastogenesis, IL 2 production and IL 2 receptor expression in T lymphocytes.
Fujiwara H; Toossi Z; Ohnishi K; Edmonds K; Ellner JJ
J Immunol; 1987 Jan; 138(1):197-203. PubMed ID: 3097146
[TBL] [Abstract][Full Text] [Related]
3. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
Tao X; Davis LS; Hashimoto K; Lipsky PE
J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
[TBL] [Abstract][Full Text] [Related]
4. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
Tadmori W; Reed JC; Nowell PC; Kamoun M
J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
[TBL] [Abstract][Full Text] [Related]
5. Tumor growth inhibitory activity of a lymphocyte blastogenesis inhibitory factor.
Sugimura K; Ohno T; Fukuda S; Wada Y; Kimura T; Azuma I
Cancer Res; 1990 Jan; 50(2):345-9. PubMed ID: 2403840
[TBL] [Abstract][Full Text] [Related]
6. Quantitative and qualitative signals determine T-cell cycle entry and progression.
Modiano JF; Mayor J; Ball C; Chitko-McKown CG; Sakata N; Domenico-Hahn J; Lucas JJ; Gelfand EW
Cell Immunol; 1999 Oct; 197(1):19-29. PubMed ID: 10555992
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of action of serum immunosuppressive factor in Crohn's disease: it blocks the growth of mitogen-stimulated lymphocytes in early G1 phase through an inhibition of transferrin receptor expression.
Iwao Y; Hibi T; Watanabe M; Takaishi H; Hosoda Y; Hayashi A; Ohara M; Ogata H; Aiso S; Toda K
J Clin Lab Immunol; 1992; 38(1):15-27. PubMed ID: 1343345
[TBL] [Abstract][Full Text] [Related]
8. Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes.
Davis L; Lipsky PE
J Immunol; 1986 May; 136(10):3588-96. PubMed ID: 3486215
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive factor produced by a B cell line derived from an adult T cell leukemia patient.
Mori N; Yamashita U; Tanaka Y; Nagata K; Nakata K; Oda S; Eto S
Int J Hematol; 1992 Aug; 56(1):29-39. PubMed ID: 1391804
[TBL] [Abstract][Full Text] [Related]
10. Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors.
Nagel JE; Chopra RK; Chrest FJ; McCoy MT; Schneider EL; Holbrook NJ; Adler WH
J Clin Invest; 1988 Apr; 81(4):1096-102. PubMed ID: 3127423
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
Chouaib S; Welte K; Mertelsmann R; Dupont B
J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
[TBL] [Abstract][Full Text] [Related]
12. Thiol-mediated redox regulation of lymphocyte proliferation. Possible involvement of adult T cell leukemia-derived factor and glutathione in transferrin receptor expression.
Iwata S; Hori T; Sato N; Ueda-Taniguchi Y; Yamabe T; Nakamura H; Masutani H; Yodoi J
J Immunol; 1994 Jun; 152(12):5633-42. PubMed ID: 8207197
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha inhibits proliferation in human T lymphocytes by abrogation of interleukin 2-induced changes in cell cycle-regulatory proteins.
Erickson S; Sangfelt O; Castro J; Heyman M; Einhorn S; Grandér D
Cell Growth Differ; 1999 Aug; 10(8):575-82. PubMed ID: 10470857
[TBL] [Abstract][Full Text] [Related]
14. Regulation of human T lymphocyte mitogenesis by antibodies to CD3.
Davis L; Vida R; Lipsky PE
J Immunol; 1986 Dec; 137(12):3758-67. PubMed ID: 3097131
[TBL] [Abstract][Full Text] [Related]
15. Promotion of human T lymphocyte proliferation by IL-4.
Mitchell LC; Davis LS; Lipsky PE
J Immunol; 1989 Mar; 142(5):1548-57. PubMed ID: 2783946
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of tumor necrosis factor-alpha and IL-1 beta on mitogen-induced T cell activation.
Hackett RJ; Davis LS; Lipsky PE
J Immunol; 1988 Apr; 140(8):2639-44. PubMed ID: 2965728
[TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes.
Kurki P; Lotz M; Ogata K; Tan EM
J Immunol; 1987 Jun; 138(12):4114-20. PubMed ID: 2884260
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of human T cell response to mitogens: IL 2 induces IL 2 receptor expression and proliferation but not IL 2 synthesis in PHA-stimulated T cells.
Katzen D; Chu E; Terhost C; Leung DY; Gesner M; Miller RA; Geha RS
J Immunol; 1985 Sep; 135(3):1840-5. PubMed ID: 3926887
[TBL] [Abstract][Full Text] [Related]
19. Desferoxamine blocks IL 2 receptor expression on human T lymphocytes.
Carotenuto P; Pontesilli O; Cambier JC; Hayward AR
J Immunol; 1986 Apr; 136(7):2342-7. PubMed ID: 3005409
[TBL] [Abstract][Full Text] [Related]
20. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
